RMD · News · 20260807N

Revenue Performance and Mix

RESMED INC · 2026-08-07 · Importance 36 · Surprise 40

ResMed's fourth-quarter fiscal 2026 revenue increased 9% year over year to a record $1.5 billion, or 8% on a constant-currency basis. Fiscal 2026 revenue increased 10% to $5.653 billion. Growth reflected continued expansion across global sleep and breathing health and residential care software, while Astral ventilator sales were affected by a field safety action. The company reported fourth-quarter GAAP diluted EPS of $2.64, up 2% year over year, and non-GAAP diluted EPS of $2.95, up 16%.

Key facts

• ResMed's Q4 revenue of $1.46 billion surpassed expectations by $3.26 million (presented as beating by $3.26 million). source